ZA200201250B - Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11. - Google Patents

Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.

Info

Publication number
ZA200201250B
ZA200201250B ZA200201250A ZA200201250A ZA200201250B ZA 200201250 B ZA200201250 B ZA 200201250B ZA 200201250 A ZA200201250 A ZA 200201250A ZA 200201250 A ZA200201250 A ZA 200201250A ZA 200201250 B ZA200201250 B ZA 200201250B
Authority
ZA
South Africa
Prior art keywords
alkyl
alkynyl
alkenyl
alpha
hydrocarbon substituent
Prior art date
Application number
ZA200201250A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Wilhelmus Gerardus Ed Schoonen
Gerrit Herman Veeneman
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200201250B publication Critical patent/ZA200201250B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200201250A 1999-09-06 2002-02-13 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11. ZA200201250B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202900 1999-09-06

Publications (1)

Publication Number Publication Date
ZA200201250B true ZA200201250B (en) 2003-07-30

Family

ID=8240610

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201250A ZA200201250B (en) 1999-09-06 2002-02-13 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.

Country Status (24)

Country Link
US (1) US6677329B1 (de)
EP (1) EP1224204B1 (de)
JP (1) JP2003508541A (de)
KR (1) KR20020092907A (de)
CN (2) CN100354299C (de)
AT (1) ATE295851T1 (de)
AU (1) AU770331B2 (de)
BR (1) BR0013769A (de)
CA (1) CA2382489C (de)
CZ (1) CZ2002831A3 (de)
DE (1) DE60020260T2 (de)
EC (1) ECSP013947A (de)
ES (1) ES2241657T3 (de)
HU (1) HUP0202595A3 (de)
IL (2) IL148116A0 (de)
MX (1) MXPA02001831A (de)
NO (1) NO20021079L (de)
NZ (1) NZ517281A (de)
PL (1) PL353826A1 (de)
RU (1) RU2245886C2 (de)
SK (1) SK3282002A3 (de)
TR (1) TR200200575T2 (de)
WO (1) WO2001018027A1 (de)
ZA (1) ZA200201250B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (de) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
TR200200575T2 (tr) * 1999-09-06 2002-06-21 Akzo Nobel N. V. 11 Konumunda bir hidrokarbon ikame ediciye sahip, aromatik olmayan östrojenik steroidler.
US8173628B2 (en) * 2000-06-22 2012-05-08 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
WO2001098322A1 (en) * 2000-06-22 2001-12-27 Northeastern University Novel steroidal antiestrogens and antiandrogens and uses thereof
BR0112791A (pt) * 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US11034716B2 (en) * 2016-03-03 2021-06-15 Crystal Pharma, S.A.U. Process and new intermediates for the preparation of 11-methylene steroids
CN114249789B (zh) * 2020-09-23 2023-06-02 湖南普尔生物医药有限公司 一种7α-甲基-3,3-二甲氧基-5(10)-雄烯-17-酮的制备方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092645A (en) * 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1112840A (en) * 1964-04-07 1968-05-08 Res Inst Medicine Chem Steroids having pro-oestrogenic activity
US3465010A (en) 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) * 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
US3652606A (en) * 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
ZA94715B (en) 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
ATE180669T1 (de) 1993-03-05 1999-06-15 Akzo Nobel Nv Verwendung von pregnanderivaten zur behandlung von tumoren
TR200002593T2 (tr) 1998-03-09 2000-12-21 Akzo Nobel N.V. Yeni bir gebelik önleme kiti
TR200200575T2 (tr) * 1999-09-06 2002-06-21 Akzo Nobel N. V. 11 Konumunda bir hidrokarbon ikame ediciye sahip, aromatik olmayan östrojenik steroidler.

Also Published As

Publication number Publication date
CN1637016A (zh) 2005-07-13
IL148116A0 (en) 2002-09-12
RU2245886C2 (ru) 2005-02-10
ES2241657T3 (es) 2005-11-01
EP1224204A1 (de) 2002-07-24
ATE295851T1 (de) 2005-06-15
JP2003508541A (ja) 2003-03-04
MXPA02001831A (es) 2002-10-23
KR20020092907A (ko) 2002-12-12
NO20021079L (no) 2002-04-29
CN1185249C (zh) 2005-01-19
AU770331B2 (en) 2004-02-19
AU7511700A (en) 2001-04-10
CZ2002831A3 (cs) 2002-05-15
CA2382489C (en) 2008-03-11
SK3282002A3 (en) 2002-06-04
EP1224204B1 (de) 2005-05-18
CA2382489A1 (en) 2001-03-15
HUP0202595A2 (hu) 2002-12-28
IL148116A (en) 2006-10-31
DE60020260T2 (de) 2006-01-19
CN1372565A (zh) 2002-10-02
CN100354299C (zh) 2007-12-12
DE60020260D1 (de) 2005-06-23
NZ517281A (en) 2003-09-26
TR200200575T2 (tr) 2002-06-21
US6677329B1 (en) 2004-01-13
ECSP013947A (es) 2002-09-27
PL353826A1 (en) 2003-12-01
BR0013769A (pt) 2002-04-30
HUP0202595A3 (en) 2004-06-28
NO20021079D0 (no) 2002-03-05
WO2001018027A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
ZA200201250B (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.
DE69327096D1 (de) 17-substituierte steroide, verwendbar bei behandlung von krebs
IL122348A0 (en) Neuroactive steroids of the androstane and pregnane series
AU665430B2 (en) 17-spiromethylene steroids
EP1310509A3 (de) Anti-östrogene Steroide, pharmazeutische Zusammensetzungen und Verwendungen davon
RS20070075A (en) 15beta-substituted steroids having selective estrogenic activity
AU1967300A (en) Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
AU2112995A (en) Use of estrone derivatives as steroid sulphatase inhibitors
NO20013632D0 (no) Steroide sulfataseinhibitorer og fremgangsmåter for å fremstille og anvende disse
KR950031081A (ko) 마약 또는 마약 혼합물 및 그들을 함유한 조성물의 작용을 자연스럽게 또는 급격히 중단함으로써 나타나는 증상과 관련된 증후군의 예방 또는 치료용 의약의 제조에 사용되는 항글루코코티코이드 활성을 갖는 화합물의 용도
RU2002108723A (ru) Неароматические эстрогенные стероиды с углеводородным заместителем в положении 11
ZA805249B (en) New amino-14 steriod derivatives and process for preparataion of the same
NO931951D0 (no) 2beta,19-metylenaminobroede steroider som aromataseinhibitorer
CA2260584A1 (en) Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation
HK1044542A1 (en) 11-Beta-aryl-17, 17-spirothiolane-substituted steroids.
CO5251432A1 (es) Derivados de 3-metileno esteroides
CO5261633A1 (es) Compuestos estrogenicos
JPS5467096A (en) Oxidation of sterols or their derivatives